Loading…
Fairholme Capital Management
Founder of Fairholme, a deep-value investor known for extremely concentrated positions held through long drawdowns.
Fairholme Capital Management reported 13 positions worth $1.49B in U.S.-listed equities as of Q2 2026. It opened 3 new positions that quarter. The largest holding is ST JOE Co (JOE), at 76.4% of the portfolio. The biggest new position was Pfizer Inc (PFE), at $5.56M.
Positions as of Q2 2026, per the 13F filed on Aug 14, 2026. Current positions may differ.
Positions opened, added to, trimmed or closed in the Q2 2026 filing.
A 13F does not report cash. It covers only U.S.-listed securities — cash, bonds, foreign stocks and private holdings are invisible in it, which is why Berkshire’s cash pile appears in its 10-Q and not here. What the filing does show is direction: selling more than buying means money left U.S. equities that quarter. Where it went — cash, fixed income, other markets — the form does not say.
Estimated across every position in each quarter, so a single stock can be compared against the whole. Same caveat as elsewhere: a 13F reports the share count on the last day of the quarter, while dividends are paid throughout it.